MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Cognitive profile in the Parkinsonian variant of multiple system atrophy: Findings from a Tunisian cohort

    A. Nasri, M. Ben Djebara, I. Kacem, Y. Sidhom, A. Gargouri, R. Gouider (Tunis, Tunisia)

    Objective: To establish the cognitive profile of MSA-P in a Tunisian cohort and to discuss its association with motor signs. Background: It has been previously…
  • 2016 International Congress

    Deep brain stimulation of the globus pallidus interna improves performance in complex oculomotor tasks

    C.A. Antoniades, P. Rebelo, C. Kennard, T. Aziz, A.L. Green, J.J. FitzGerald (Oxford, United Kingdom)

    Objective: To compare and contrast the effects of deep brain stimulation of (a) the subthalamic nucleus and (b) the globus pallidus interna on advanced Parkinson's…
  • 2016 International Congress

    Associations between cerebrospinal fluid proteins and cytokines in Parkinson’s disease

    R. Wijeyekoon, S. Moore, K. Farrell, D. Breen, R. Barker, C.H. Williams-Gray (Cambridge, United Kingdom)

    Objective: To investigate the relationship between cerebrospinal fluid (CSF) proteins and cytokines, and their correlation with clinical measures in PD. Background: Several studies have investigated…
  • 2016 International Congress

    Dynamic dopamine transporter images are helpful for diagnosing parkinsonism

    K. Abe, K. Fukushima, T. Katuura, K. Kitajima, Y. Maeda, K. Hahiskawa, H. Yoshikawa (Nishinomiya, Japan)

    Objective: This study is aimed at introducing a new method to get Dopamine transporter (DAT) imaging simultaneously with regional cerebral flow (CBF) imaging. Background: DAT…
  • 2016 International Congress

    Correlation between neuro-behavioral symptoms, cognition and gait in patients with dementia with Lewy bodies (DLB)

    B. Tousi, L. Mourany (Cleveland, OH, USA)

    Objective: To determine the prevalence of neurobehavioral disturbances and their relationship to gait and cognitive impairment in DLB. Background: The recent literature has conceptualized that…
  • 2016 International Congress

    Neuropsychological assessment in a cohort of patients with Parkinson’s disease

    C. Juri, W. Uslar, H. Farias, M. Vasquez (Santiago, Chile)

    Objective: To evaluate the cognitive profile in a cohort of patients with Parkinson's disease (PD) using a standardised battery. Background: Cognitive impairment is a great…
  • 2016 International Congress

    Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease

    J.R. Zhang, J. Chen, Z.J. Yang, H.J. Zhang, Y.T. Fu, Y. Shen, P.C. He, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)

    Objective: To investigate (1) the domains of cognitive impairment in patients with Parkinson's disease (PD) and rapid eye movement sleep behavior disorder (RBD). (2) To…
  • 2016 International Congress

    Dopamine modulates learning conflicting action-valence associations in Parkinson’s disease

    N.C. van Wouwe, D.O. Claassen, J.S. Neimat, S.A. Wylie (Nashville, TN, USA)

    Objective: To investigate the effect of dopaminergic medication in Parkinson's disease (PD) on learning to act and learning to withhold action based on rewarding versus…
  • 2016 International Congress

    Staging of cognitive impairment: Validation of a novel cognitive score with [18F]FDG-PET

    D. Blum, M. Reimold, W. Maetzler, C. la Fougère, G. Reischl, D. Berg, I. Liepelt-Scarfone (Tübingen, Germany)

    Objective: To provide insight into the nature of cognitive deterioration and Parkinson's disease dementia (PDD) and to validate a novel cognitive score (also submitted for…
  • 2016 International Congress

    Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia

    N.G. Sokhibnazarov, F.K. Shermukhamedova (Tashkent, Uzbekistan)

    Objective: Aim of this study was to identify the degree of cognitive dysfunction in patients with subcortical Parkinsonian dementia, during the neuroprotective therapy. Background: Parkinson's…
  • « Previous Page
  • 1
  • …
  • 119
  • 120
  • 121
  • 122
  • 123
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley